secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2026-06-24T20:24:12+00:00
Accession:  0001841387-26-000009
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Candel shareholders elect four Class II directors, ratify KPMG as auditor at June 23 annual meeting
--------------------------------------------------------------------------------

- Elected Edward J. Benz, Paul B. Manning, Maha Radhakrishnan, and Paul Peter Tak as Class II directors for three-year terms.
- Director voting: Benz received 24.9M for, 6.8M withheld; Manning 31.6M for, 102k withheld; Radhakrishnan 31.0M for, 646k withheld; Tak 31.4M for, 279k withheld.
- KPMG LLP ratified as independent auditor for FY 2026 with 53.5M for, 238k against, 88k abstain.
- All proposals passed; no other matters were voted on at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/0001841387-26-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/cadl-20260623.htm
  HTML page:      https://secwatch.observer/filing/0001841387-26-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer